We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.44B
AUM Growth
+$225M
Cap. Flow
-$55.1M
Cap. Flow %
-1.6%
Top 10 Hldgs %
13.72%
Holding
457
New
29
Increased
62
Reduced
284
Closed
34

Top Buys

Rank Stock Value
1
VC icon
Visteon
VC
+$15.3M
2
QCOM icon
Qualcomm
QCOM
+$6.79M
3
CMCO icon
Columbus McKinnon
CMCO
+$5.89M
4
CVS icon
CVS Health
CVS
+$5.8M
5
IBM icon
IBM
IBM
+$5.73M

Top Sells

Rank Stock Value
1
CF icon
CF Industries
CF
+$10.4M
2
LMT icon
Lockheed Martin
LMT
+$8.81M
3
CSCO icon
Cisco
CSCO
+$6.28M
4
PYPL icon
PayPal
PYPL
+$6.14M
5
MSFT icon
Microsoft
MSFT
+$6.02M

Sector Composition

Rank Sector Weight
1 Technology 20.28%
2 Financials 16.52%
3 Industrials 12.39%
4 Consumer Discretionary 11.85%
5 Healthcare 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRVI icon
376
Maravai LifeSciences
MRVI
$884M
$994K 0.03%
23,715
FLL icon
377
Full House Resorts
FLL
$91.2M
$978K 0.03%
80,790
-23,174
-22% -$251K
NTLA icon
378
Intellia Therapeutics
NTLA
$1.67B
$974K 0.03%
8,239
-158
-2% -$19.8K
ATKR icon
379
Atkore
ATKR
$3.17B
$971K 0.03%
+8,734
New +$887K
BAX icon
380
Baxter International
BAX
$13.9B
$943K 0.03%
10,988
STVN icon
381
Stevanato
STVN
$5.46B
$927K 0.03%
41,275
-816
-2% -$19.4K
DBRG icon
382
DigitalBridge
DBRG
$2.95B
$923K 0.03%
+27,697
New +$824K
ATRC icon
383
AtriCure
ATRC
$2.11B
$919K 0.03%
13,215
-407
-3% -$29.6K
CTLT
384
DELISTED
CATALENT, INC.
CTLT
$891K 0.03%
6,959
PH icon
385
Parker-Hannifin
PH
$135B
$885K 0.03%
2,782
+1,287
+86% +$398K
ALB icon
386
Albemarle
ALB
$15.6B
$873K 0.03%
3,732
BAND
387
Bandwidth Inc
BAND
$1.63B
$868K 0.03%
12,094
-216
-2% -$16.8K
TER icon
388
Teradyne
TER
$59.6B
$800K 0.02%
4,892
PWR icon
389
Quanta Services
PWR
$102B
$790K 0.02%
6,895
RNG icon
390
RingCentral
RNG
$5.3B
$768K 0.02%
4,103
DAR icon
391
Darling Ingredients
DAR
$9.65B
$739K 0.02%
10,671
CNTY icon
392
Century Casinos
CNTY
$33.2M
$717K 0.02%
58,846
-1,203
-2% -$16.9K
DOMO icon
393
Domo
DOMO
$183M
$696K 0.02%
14,035
-12,399
-47% -$911K
FATE icon
394
Fate Therapeutics
FATE
$325M
$685K 0.02%
11,708
-207
-2% -$11.7K
TTI icon
395
TETRA Technologies
TTI
$1.27B
$676K 0.02%
238,178
-4,060
-2% -$12.5K
DXCM icon
396
DexCom
DXCM
$32B
$649K 0.02%
4,832
SHY icon
397
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$622K 0.02%
7,270
+2,005
+38% +$172K
IVV icon
398
iShares Core S&P 500 ETF
IVV
$905B
$613K 0.02%
1,286
-330
-20% -$152K
CSTL icon
399
Castle Biosciences
CSTL
$955M
$596K 0.02%
13,901
-245
-2% -$12.8K
NBIX icon
400
Neurocrine Biosciences
NBIX
$16.5B
$560K 0.02%
6,572

Similar funds

Chartwell Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Chartwell Investment Partners held 457 positions worth $3.44B, up 7% from $3.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Chartwell Investment Partners's Q4 2021 filing shows 29 new, 62 increased, 284 reduced and 34 closed positions. Its largest new stake was Visteon: 137,624 shares worth $15.3M. The largest sale was CF Industries, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Chartwell Investment Partners's largest Q4 2021 buy was Visteon: 137,624 shares worth $15.3M.
  • Chartwell Investment Partners added most to Columbus McKinnon in Q4 2021, an estimated $5.89M increase.
  • Chartwell Investment Partners's biggest Q4 2021 reduction was CF Industries, cutting an estimated $10.4M.
  • Chartwell Investment Partners fully exited Saia in Q4 2021, selling an estimated $5.35M.
  • Chartwell Investment Partners's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2021.
  • Chartwell Investment Partners opened 29 new positions and closed 34 in Q4 2021.
  • Chartwell Investment Partners's portfolio value rose 7% quarter-over-quarter to $3.44B.

Based on Chartwell Investment Partners's 13F filing for Q4 2021, filed 15 Feb 2022.